Volume : 09, Issue : 02, February – 2022

Title:

15.FORMULATION DEVELOPMENT AND EVALUATION OF FAST DISSOLVING ORAL FILM OF ATORVASTATIN CALCIUM

Authors :

Sufiya Tahseen*, Dr. Vishnu raj, Dr. Brijesh Sirohi, Dr. S.K. Lariya

Abstract :

Fast dissolving oral films (FDOFs) are the most advanced form of oral solid dosage form due to more flexibility and comfort. It improve the efficacy of APIs by dissolving within minute in oral cavity after the contact with less saliva as compared to fast dissolving tablets, without chewing and no need of water for administration. Atorvastatin is a lipid lowering agent and widely used to treat hypercholestermia. However following oral administration, the bioavailability of the drug is only 12% due to extensive first pass metabolism. The aim of present work is to formulate and evaluate fast dissolving oral films of atorvastatin calcium to improve water solubility, dissolution rate, oral bioavailability and reduction of first pass metabolism and increase patient’s compliance. Oral fast dissolving films prepared by solvent casting method using water and 95% ethanol as solvents and HPMC as film forming polymer. PEG 400 was the selected plasticizers, Superdisintegrants such as croscarmellose sodium (CCS), crospovidone (CP) and sodium starch glycolate (SSG) alone and also in combinations was incorporated to achieve the aim. The prepared films were evaluated for the drug content, weight variation, film thickness and disintegration time, folding endurance, percentage of moisture content and in vitro dissolution studies and taste mask studies on healthy human volunteers. Among all, the formulation F4 was found to be best formulation which releases 98.95 % of the drug within 15 min and disintegration time is 168sec. which was significantly high when compared to other formulation. The results revealed that, atorvastatin fast dissolving oral films could be considered as promising drug delivery system for hyperlipidemic patients.
Keywords: Atorvastatin, Hypercholestermia, Fast dissolving films, Solvent casting method, Superdisintegrants.

Cite This Article:

Please cite this article in press Sufiya Tahseen et al Formulation Development And Evaluation Of Fast Dissolving Oral Film Of Atorvastatin Calcium., Indo Am. J. P. Sci, 2022; 09(02). .

Number of Downloads : 10

References:

1. Arya A, Chandra A, Sharma V, Pathak K (2010) Fast Dissolving Oral Films: An Innovative Drug Delivery System And Dosage Form. Int J of ChemTech Research 2: 576-583.
2. Naziya Khatoon NG, Raghavendra Rao B, Mahipal Reddy (2013) Overview on fast dissolving oral films. International Journal of Chemistry and Pharmaceutical Sciences 1: 63-75.
3. Gautam SP, Rai JP, Billshaiya U, Jain N, Vikram P, Jain DK. Formulation and evaluation of mouth dissolving tablet of loperamide. Int J Pharm Sci Res. 2013; 4(5): 1782-1788.
4. Shah D, Bhatt K, Shankar M, Mehta R, Gandhi T, Baldania S. (2006). RP-HPLC determination of Atorvastatin calcium and Amlodipine besylate combination in tablets. Ind J Pharm Sci, 68:796–799.
5. Shaik HR, Ramakotaiah M, Vani PS, Arief M, Gajavalli SR. (2010). A stability-indicating LC method for the simultaneous determination of Metoprolol, Atorvastatin and Ramipril in combined pharmaceutical dosage form. Res J Pharm, Biol and Chem Sci, 1: 816–29.
6. http://www.rxlist.com/lipitor-drug.htm, Accessed on 10th October 2009.
7. http://www.drugbank.ca/drugs/DB01076, Accessed on 10th October 2009.
8. Shete G, Puri V, Kumar L, Bansal AK. (2010). Solid state characterization of commercial crystalline and amorphous atorvastatin calcium samples. AAPS PharmSciTech, 11:598–609.
9. Bobe K, Subrahmanya C, Suresh S, Gaikwad D, Patil M, Khade T, et al. (2011). Formulation and evaluation of solid dispersion of Atorvatstatin with various carriers. Int J Compre Phar, 1:1–6.
10. Eroglu H, Nemutlu E, Turkoglu OF, Nacar O, Bodur E, Sargon MF et al. (2010). A quadruped study on chitosan microspheres containing atorvastatin calcium: preparation, characterization, quantification and in-vivo application. Chem Pharm Bull, 58:1161–1167.
11. Yin YM, Cui FD, Kim JS, Choi MK, Choi BC, Chung SJ et al. (2009). Preparation, characterization and in vitro intestinal absorption of a dry emulsion formulation containing atorvastatin calcium. Drug Deliv, 16:30–36.
12. Talegaonkar S, Mustafa G, Akhter S, Iqbal Z. (2010). Design and development of oral oil-in-water nanoemulsion formulation bearing Atorvastatin: in vitro assessment. J Disp Sci Tech, 31:690–701.
13. Arunkumar N, Deecaraman M, Rani C, Mohanraj K, Venkateskumar K. (2009). Preparation and solid state characterization of Atorvastatin nanosuspensions for enhanced solubility and dissolution. Int J Pharm Tech Res, 1: 1725–1730.
14. Chouksey R, Pandey H, Jain AK, Soni H, Saraogi GK. (2011). Preparation and evaluation of the self emulsifying drug delivery system containing Atorvastatin HMG-COA inhibiter. Int J Phar Pharm Sci, 3:147–152.
15. Aguiar AJ, Krc J Jr, Kinkel AW, Samyn JC. (1967). Effect of polymorphism on the absorption of chloramphenicol from chloramphenicol palmitate. J Pharm Sci, 56:847–853.
16. K. Senthilkumar and C. Vijaya. Formulation development of mouth dissolving film of etoricoxib for pain management. Advances in Pharmaceutics. 2015, Article ID 702963.
17. Kumar GV, Krishna RV, William GJ, Konde A. Formulation and evaluation of buccal films of Salbutamol sulphate. Ind J Pharm Sci 2005; 67: 160–164.
18. Mona Nagar, Mayank Nagar and Vikram Chopra, Formulation and evaluation of mouth dissolving film of antipsychotic drug aripiprazole, Der Pharm Lett 2012; 4 (4): 1221- 1227.
19. Prabhu P, Malli R, Koland M, Vijaynarayana K, D’Souza U, Harish NM, Shastry CS. Formulation and evaluation of fast dissolving films of levocetrizine dihydrochloride, Int J Pharm Inves 2011;1(2): 99–104. 17.
20. Nafee NA, Boraie MA, Ismail FA, Mortada LM. Design and characterization of mucoadhesive buccal patches containing cetylpyridinium chloride. ACTA Pharm 2003; 53: 199–212.